Clinical Insomnia

Rule Out Disorders

At any given time, over forty percent of us report difficulty getting to sleep or staying asleep during attempted sleep periods. Despite the huge numbers that these percentages imply, individuals with clinical insomnia form a much smaller subset of those reporting insomnia. So what about all of those highly frustrated individuals reporting insomnia that do not meet the criteria of a clinical insomnia subclass? It turns out that if they were put through a systematic process, many would show indications of other common sleep disorders in tandem with maladaptive beliefs and behaviors associated with sleep. Some would, indeed, present with clinical insomnia.
The process of addressing insomnia complaints requires first ruling out other common sleep disorders with overlapping symptoms. This includes obstructive sleep apnea (OSA), restless legs syndrome (RLS), periodic limb movement disorder (PLMD) and many other possible disorders. If any of these disorders are suspected they must be addressed as a priority even while continuing the investigative process of identifying OTHER contributions to insomnia, such as medication use, hyperarousal, circadian mistiming, or maladaptive behaviors. In practice— all of the components that contribute to insomnia, including other medical conditions, should be addressed.

Learn About Sleep & Health

 Sleep ApneaEmotion/CognitionWeight-LossProductivityTreat OSA

Cognitive Therapy

According to the AASM it is not advised to address insomnia complaints by asking your physician to prescribe a sleep aid for long-term use without addressing the many factors that contribute to delayed sleep onset or poor sleep quality in general. Chronic insomnia complaints should be referred to a sleep specialist to evaluate, or a process that can be taken up by a sleep specialist. A sleep specialist has at their disposal a much wider range of options and evaluation tools designed to address the multiple components that cause clinically significant sleep disturbances. The key is to treat all the components.

The American Academy of Sleep Medicine (AASM) clinical guidelines for the evaluation and management of chronic insomnia consider behavioral treatment options, such as Cognitive Behavioral Therapy for Insomnia (CBT-I), to be a recommended 'first line treatment option. CBT-I is a combination of component behavioral therapy interventions, including therapeutic protocols derived from: (1) Sleep Restriction Therapy; (2) Stimulus Control Therapy; (3) Relaxation-Based Interventions; (4) Cognitive Strategies; and (5) Sleep Hygiene Education.

Factors that require evaluation and management include: a hyperarousal tendency, excessive worrying or rumination, poor sleep habits, and poor sleep scheduling.
Although CBT-I connotes a psychotherapeutic approach, an effective CBT-I program must address the vicious cycle that links the cognitive realm of disruptive thoughts about sleep, with the physiological underpinnings of sleep that become altered over time.

AASM clinical guidelines for the management of chronic insomnia also emphasize that sleep medicines do not provide sustained improvement after their discontinuation. Pharmacological interventions such as benzodiazepine receptor agonist medications (sleep meds) were once considered the primary first-line treatment option but now CBT-I is gaining traction with validation studies and clinical guidelines that discuss it as one of the preferred treatments for insomnia. Because over-the-counter medications or herbal and natural substances are not verified in scientifically validated studies for long-term use in chronic insomnia cases, CBT-I is currently the only 'natural' treatment modality that has undergone validation in scientific studies for long-term efficacy. CBT-I may be offered by appropriately credentialed therapists in a face-to-face setting, or as part of a self-paced online set of interactive modules similar to that offered by the commercially available programs SHUTi and SLEEPIO.

Customer Service

203-456-6309

It's Time To Evolve.